A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer
The Affiliated Hospital of Qingdao University
The Affiliated Hospital of Qingdao University
Pharmacosmos A/S
China Medical University, China
Peking Union Medical College Hospital
Tang-Du Hospital
Genentech, Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Chifeng Municipal Hospital
University of Kansas Medical Center
Guangdong Association of Clinical Trials
Fox Chase Cancer Center